Study for Ongoing Safety Monitoring of a Study Drug

Sponsor: Eli Lilly and Company

Expanded Access
Sponsor score: 60
Inactive

ClinicalTrials ID:NCT02632994

Provider View

This clinical trial is for patients who have been part of a previous study and are still benefiting from the study drug. It allows them to continue receiving the treatment.

Patient Parameters

Program Overview

The purpose of this study is to provide patients who have participated in a previous clinical trial and are still benefiting from the study drug with continued access to the treatment. This ensures that patients can keep receiving the medication that has been helping them.

Eligibility Criteria

Inclusion Criteria

  • Patients must currently be benefiting from a completed Lilly study for a drug that has an open addendum in the continued access protocol.

Exclusion Criteria

  • Patients cannot be part of any other medical research that is not considered scientifically or medically compatible with this study.

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.